GRAVINA, CARMEN
 Distribuzione geografica
Continente #
EU - Europa 90
NA - Nord America 36
AS - Asia 24
OC - Oceania 2
SA - Sud America 1
Totale 153
Nazione #
IT - Italia 59
US - Stati Uniti d'America 35
CN - Cina 13
SE - Svezia 10
SG - Singapore 7
DE - Germania 5
FI - Finlandia 5
FR - Francia 3
IE - Irlanda 3
AU - Australia 2
BG - Bulgaria 2
IN - India 2
RS - Serbia 2
GB - Regno Unito 1
ID - Indonesia 1
IL - Israele 1
MX - Messico 1
PE - Perù 1
Totale 153
Città #
Rome 20
Pellezzano 9
Milan 7
Changsha 6
Helsinki 4
Yantai 4
Boardman 3
Chandler 3
Dublin 3
Fiumicino 3
Frankfurt am Main 3
Singapore 3
Turin 3
Ashburn 2
Los Angeles 2
New York 2
Piancogno 2
Shenzhen 2
Sofia 2
Svilajnac 2
Sydney 2
Azcapotzalco 1
Bandung 1
Bremen 1
Edinburgh 1
Florence 1
Jaipur 1
Lappeenranta 1
Lima 1
Pune 1
Tel Aviv 1
Vreden 1
Totale 98
Nome #
Patients’ Preferences and Expectations in Overactive Bladder: A Systematic Review 26
Serum levels of chromogranin are not predictive of poorly differentiated prostate cancer: Results from a multicenter radical prostatectomy cohort 21
Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries 19
Medications mostly associated with hematuria: assessment of the EudraVigilance and Food and Drug Administration pharmacovigilance databases entries 18
Post-voided residual urine ratio as a predictor of bladder outlet obstruction in men with lower urinary tract symptoms: development of a clinical nomogram 17
Ureteral wall thickness and distal ureteral density in patients with residual fragments after Ho:YAG laser semi-rigid ureterolithotripsy 14
Metabolic syndrome evaluation improves prostate cancer detection in patients undergoing a repeat biopsy 13
null 13
Trends and incidence of reported events associated with ureteral stents: An analysis of the food and drug administration’s manufacturer and user facility device experience database 12
Adverse events related to antimuscarinics and beta-3-agonist. "real-life" data from the Eudra-Vigilance Database 10
Role of Perilesional Sampling of Patients Undergoing Fusion Prostate Biopsies 9
Adverse events related to darolutamide treatment: analysis of "real life" data from EudraVigilance and the Food and Drug Administration database entries 6
Re: Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.008 4
Trends and incidence of reported events associated with ureteroscopes: An analysis of the food and drug administration’s manufacturer and user facility device experience database 3
Trends and incidence of reported events associated with male slings: An analysis of the food and drug administration’s manufacturer and user facility device experience database 2
Re: Edward Lambert, Emmanuel Chartier-Kastler, Christophe Vaessen, et al. Robot-assisted Periprostatic Artificial Urinary Sphincter Implantation in Men with Neurogenic Stress Urinary Incontinence: Description of the Surgical Technique and Comparison of Long-term Functional Outcomes with the Open Approach. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.09.025 2
Re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.10.010 1
Totale 190
Categoria #
all - tutte 1.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202382 0 1 1 7 1 1 14 19 27 1 5 5
2023/2024108 3 12 5 9 7 27 2 16 6 17 4 0
Totale 190